Research Row: Approved or on the Horizon Join us as we discuss Approved Therapies and those on the Horizon of approval. Santhera Pharmaceuticals (Vamorolone) Italfarmaco ( Givinostat) PTC Pharmaceuticals (Ataluren, Emflaza) Sarepta Therapeutics (Amondys45, Exondys 51, Vyondys53) NS Pharma (Viltepso) 2023 PPMD Annual Conference,Conferences & Meetings 1 year ago You may also like 1:31:49 The Complexities of Duchenne (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:36:00 Addressing the Complexities of Duchenne (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:05:53 Quality of Life and Emotional Health (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 18:59 Our Stories Matter – Lance Hester (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 57:01 Gene Therapy: What We Know Today & Will Need to Know Tomorrow (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings gene therapy 1:44:16 Gene Therapy Trials (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings gene therapy 59:45 Downstream (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 14:33 Our Stories Matter – Stephen Marchesani (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings «1…22232425»Page 24 of 25
by: Parent Project Muscular Dystrophy
